b b b b b b b b b
Writing
b
Haveles: Applied Pharmacology for the Dental Hygienist, 9th Edition
b b b b b b b b
MULTIPLECHOICE
1. Knowledgeofpharmacologyaidsthedentalprofessionalin B B B
a. obtainingapatient’shealth history. B B
b. administeringdrugsintheoffice. B
c. handlingemergencysituations.
d. selection ofa nonprescription medication. B b B
e. Alloftheabove. B B
ANS: E B B
Allofthechoicesaretrue.Becausemanyofourpatientsarebeingtreatedwithdrugs,knowledgeof
B B B B B B B B B B B B B B B B
pharmacologyhelpsinunderstandingandinterpretingpatients’responsestohealthhistoryquestions.
B B
Knowledgeofthetherapeuticandadverseeffectsofmedicationsobviouslyhelpsintheirproper
B B B B B B B B B B B B
administrationintheoffice.Emergencysituationsmaybecausedbydrugsortreatedbydrugs;thus, knowledge
B B B B B B B B B B B B B B B B
ofpharmacologyisofgreathelp,especiallybecausearapidresponseissometimesrequired.A clear
B B B B B B B B B B B B B B B B
understandingoftheconceptsofdrugaction,drughandlingbythebody,anddruginteractionswill allowthe
B B B B B B B B B B B B B B B B B
dentalpractitionertomakeproperjudgmentsandgrasptheconceptsrelevanttonewdrug therapiesonthe
B B B B B B B B B B B B B B B B
market.
B
DIF: Application
REF: RoleoftheDentalHygienist(Medication/HealthHistory),RoleoftheDentalHygienist(Medication
B B B B B B B B B B B B B
Administration),RoleoftheDentalHygienist(EmergencySituations),RoleoftheDentalHygienist
B B B B B B B B B B B B B
(NonprescriptionMedication) |pp. 2-3
B OBJ: 1 B B B B
TOP: NBDHE,6.0.Pharmacology
B B B B
2. Whichofthefollowingstatementsistrueregardingplanningappointments? B B B B
a. Whetherornotpatientsaretaking medicationforsystemicdiseasesisoflittle B B B b B B B B B B
consequenceinthedentaloffice.
B B B
b. Asthmaticpatientsshouldhavedental appointments inthemorning. B B B B
c. Diabeticpatientsusuallyhavefewerproblemswith amorningappointment b B
comparedwithafternoonappointments.
B B B B
d. BothBandCaretrue. B B
ANS: D B B
Asthmaticpatientswhoexperiencedentalanxietyshouldscheduletheirappointmentswhentheyarenot B
Brushedorunderpressureearlyinthemorning.Diabeticpatientsusuallyhaverelativelyfewerproblems
B B B B B B B B B B B B B
withamorningappointment.Patientstakingmedicationforsystemicdiseasesmayrequirespecial handling
B B B B
inthedentaloffice.
B B B
DIF: Comprehension
REF: RoleoftheDentalHygienist(AppointmentScheduling)|p.3
B B B B B B B B B
OBJ: 1
B TOP: NBDHE,6.0. Pharmacology
B B B B
,3. Nutritionalorherbalsupplements B
a. carrytheU.S.FoodandDrugAdministration(FDA)approvalfordiseasestates. B B B B B B B B B
b. arenotdrugs. B
c. cancauseadverseeffects. B B
d. willnotinteractwithotherdrugsthepatient maybetaking. B B B b B
ANS: C B B
Nutritionalorherbalsupplementsarequitecapableofcausingadverseeffects. Themajorityof nutritional or B B B
herbal supplements do not carry FDA approval for treating disease states. These supplements are drugs and can
B B B B B B B B B B B B B B B B B
causeadverseeffectsandinteractwithdifferentdrugs.
B B B B B B B B
DIF: Comprehension B B
REF: RoleoftheDentalHygienist(NutritionalorHerbalSupplements)|p.3
B B B B B B B B B B B B
OBJ: 1
B TOP: NBDHE,6.0. Pharmacology
B B B B
4. Whichtypeofdrugnameusuallybeginswithalowercaseletter? B B B B
a. Brandname
b. Codename
c. Generic name b
d. Tradename
ANS: C B B
Beforeanydrugis marketed, itisgiven agenericnamethatbecomesthe“official” nameofthedrug. Each drug B B B B B B B B B B
isassignedonlyonegenericnameselectedbytheU.S.AdoptedNameCouncil,andthenameisnot capitalized.
B B B B B B B B B B B B B B B B B B
Thebrandnameisequivalenttothetradenameandiscapitalized.Althoughthebrandnameis
B B B B B B B B B B B B B
technicallythenameofthecompanymarketingtheproduct,thistermisoftenusedinterchangeablywith the
B B B B B B
tradename.Thecodenameistheinitialtermusedwithinapharmaceuticalcompanytorefertoadrug whileit
B B B B B B B B B B B B B B B B B B B B
isundergoinginvestigationandisoftenacombinationofcapitallettersandnumbers,theletters representing
B B B B B B B B B B B B B B B
an abbreviation ofthe company name.
B B B B B B
DIF: Comprehension REF: Drug Names|p.4 B b B
OBJ: 3
B TOP: NBDHE,6.0. Pharmacology
B B B B
5. Adrug’s genericnameisselected bythe
B B B
a. pharmaceuticalcompanymanufacturing it. B
b. FoodandDrugAdministration(FDA). B B B B
c. U.S.AdoptedNameCouncil. B B B
d. FederalPatentOffice. B B
ANS: C B B
Eachdrugisassignedonlyonegenericname(e.g.,ibuprofen).ItisselectedbytheU.S.AdoptedName Council.
B B B B B B B B B B B B B B B B B
ThegenericnameisnotselectedbytheFDAortheFederalPatentOffice.Thepharmaceutical
B B B B B B B B B B B B B B
companymanufacturingthedrugclearlyhas aninfluenceonthegenericname givenits drug,but thefinal decision
B B B B B B B B B
isnotthecompany’s.
B B B
DIF: Recall REF: Drug Names |p. 4 B B B B B OBJ:
B3 TOP: NBDHE,6.0.Pharmacology
B B B B
6. Whichofthefollowingistrueconcerninggeneric andtradenamesofdrugs? B B B B B
a. Adrugmayonlyhaveonegenericname andonetradename. B B B B B B
, b. Adrugmayonlyhaveonegenericname,butitmayhaveseveraltradenames. B B B B B B B B
c. Adrugmayhaveseveral genericnames, but itmayonlyhaveonetradename. B B B B B B B
d. Adrugmayhaveseveral genericnames andseveraltradenames. B B B B B
ANS: B B B
Eachdrughasonlyonegenericnamebutmayhaveseveraltradenames.Foreachdrug,thereisonlyone generic
B B B B B B B B B B B B B B B B B B B B
name.Itisnotcapitalized,anditbecomesthe“official”nameofthedrug.Thepharmaceutical company
B B B B B B B B B B B B B B B B B
discoveringthedruggivesthedrugatradename.ThetradenameisprotectedbytheFederal Patent Lawfor20
B B B B B B B B B B B B B B B B
yearsfromtheearliestclaimedfilingdate,pluspatentterm extensions.Althoughthe
B B B B B
brandnameistechnicallythenameofthecompanymarketingtheproduct, it is often used interchangeably
B B B B B B B B
withthetradename.
B B B
DIF: Comprehension REF: Drug Names|p.4 B b B
OBJ: 3
B TOP: NBDHE,6.0. Pharmacology
B B B B
7. Twodrugsthatarefoundtobechemicallyequivalent,butnot biologicallyequivalentor B B B b
B therapeuticallyequivalent aresaid todifferin B B B B B
a. potency.
b. efficacy.
c. bioavailability.
d. therapeuticindex.
ANS: C B B
Apreparationcanbechemicallyequivalentyetnotbiologicallyortherapeuticallyequivalent.These
B B B B B B B B B B B
productsaresaidtodifferintheirbioavailability. Thepotencyof adrugisafunctionoftheamountof drug
B B B B
Brequiredtoproduceaneffect.Theefficacyisthemaximumintensityofeffectorresponsethatcanbe produced
B B B B B B B B B B B B B B B B B B
byadrug.Thetherapeuticindexistheratioofthelethaldosefor50%oftheexperimental animalsdividedbythe
B B B B B B B B B B B B B B B B B B B B B
effectivedosefor50%oftheexperimentalanimals.Ifthevalueofthetherapeutic indexissmall,toxicityismore
B B B B B B B B B B B B B B B B B B
likely.
B
DIF: Recall REF: DrugNames (Drug Substitution)|p.5 B b B B
OBJ: 4
B B TOP: NBDHE,6.0. Pharmacology B B B
8. Howmanyyearsmust pass afteradrug patentexpiresbeforeotherdrugcompanies can marketthe same b B B B
B compoundasagenericdrug? B B B B
a. 20years B
b. 17years B
c. 7years B
d. 0years B
ANS: D B B
Onceadrugpatentexpires,competingcompaniesmayimmediatelymarketthesamecompoundin generic
B B B B B B B B B B B B B B
form.Thepharmaceuticalcompanydiscoveringthedruggivesthedrugatradename.Thetrade
B B B B B B B B B B B B B B
nameisprotectedbytheFederalPatent Lawfor20yearsfromtheearliestclaimedfilingdate,plusthe patent
B B B B B B B B
termextensions.
B B
DIF: Application REF: DrugNames (Drug Substitution)|p.5 B b B B
OBJ: 4
B B TOP: NBDHE,6.0. Pharmacology B B B